Skip to main content

Supernus Pharmaceuticals Inc (NASDAQ:SUPN) Investor Investigation Concerning Possible Violations Of Securities Laws Announced

  • Investors who purchased shares of Supernus Pharmaceuticals Inc (NASDAQ:SUPN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

An investigation on behalf of investors of Supernus Pharmaceuticals Inc (NASDAQ:SUPN) shares over potential securities laws violations by Supernus Pharmaceuticals and certain of its directors and officers in connection with certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Supernus Pharma...



You must register (for free) or login to view the entire investigation.